antibiotics is to mimic nature by synthesizing novel deoxyami-
nosugars then to couple them to an aminocyclitol core. These
new aminoglycoside analogues may be the next generation
of nonresistant antibiotics.
Scheme 2
Structure activity relationship analysis of the carbohydrate
portions of the aminoglycosides in terms of antibiotic
resistance reveals two common structural motifs that impart
prolonged bioactivity: the presence of both deoxyamino-
sugars and deoxysugars (Figure 1). The replacement of a
hydroxyl group with an amino group installs an improved
hydrogen-bond acceptor. In contrast, the removal of a
hydroxyl group imparts in vitro stability by lessening the
abilities of naturally occurring glycosidase enzymes to
degrade the structure.3 This approach can be used by
synthetic chemists to improve binding and to overcome the
accompanying resistance that all antibiotics eventually incur.
For the past 5 years our group has been developing
methods for the enantioselective synthesis of carbohydrates
with the goal of accessing uniquely functionalized aminogly-
coside antibiotics (Scheme 1). Previous structure activity
Recently, our group has successfully employed asymmetric
catalysis for the synthesis of D- and L-sugars and iminosugars
from the achiral vinylfuran via chiral furans 4 and 6 (Scheme
9
-11
2).
Four hexoses of the type 5 were prepared from
monoprotected diol 4 in 4-6 steps, as well as the analogous
C-6 aminosugars 7 from furan 6. Similarly this route should
allow for access to unnatural C-2/C-3 dideoxysugars. We
envisioned that C-2 and C-2/C-3 deoxysugars could be
derived from the same intermediates 9 and 10 (Scheme 3)
Scheme 1
Scheme 3
that were used for the syntheses of 5 and 7. Reported herein
are our successful efforts at the conversion of intermediates
studies of the aminoglycoside antibiotics have used semi-
synthesis techniques to strategically remove hydroxyl groups
from the existing aminoglycosides, followed by the addition
9
and 10 into both C-2 deoxysugars and C-2/C-3 dideoxy-
sugars. This approach allows for access to either enantiomer
of N-Cbz-protected and O-TBS-protected C-2 deoxy-allo-
and deoxy-galactosugars and C-2/C-3 dideoxy-gluco- and
galacto-sugars.
8
of functional groups of interest. A complementary approach
is to start with a drastically simplified structure and to
sequentially increase its stereochemical and functional
complexity (e.g., 2 to 1). To implement this strategy, a
flexible route to D- and L-sugars that allows for the synthesis
of various stereoisomers and deoxyanalogues was developed.
Our earlier work has shown that the C-6 O-TBS-protected
and C-6 N-Cbz-protected pyran allylic alcohols 9 and 10
were diastereoselectively produced from furfural in 47% and
9
Having successfully addressed the synthesis of sugars,
1
1
1
4% yields, respectively (Scheme 3). The asymmetry of 9
10
11
iminosugars, and aminosugars (Scheme 2), our next goal
was to apply this methodology to the catalytic asymmetric
synthesis of deoxysugars.
was effectively introduced by a Sharpless dihydroxylation
1
2
of vinylfuran (>90% ee). In contrast, the asymmetry of
0 was ineffectively introduced in terms of enantio- and
1
regioselectivity by the Sharpless aminohydroxylation; how-
(8) (a) Umezawa, S.; Tsuchiya, T. Total Synthesis and Chemical
Modification of the Aminoglycoside Antibiotics. In Aminoglycoside Anti-
biotics; Hooper, I. R., Umezawa, H., Eds.; Springer-Verlag: NewYork,
ever, very high enantioexcess (>98% ee) was achieved with
the Noyori hydrogenation of a furyl ketone.
13,14
1982. (b) Okuda, T.; Ito, Y. Biosynthesis and Mutasynthesis of Aminogly-
coside Antibiotics. In Aminoglycoside Antibiotics; Hooper, I. R., Umezawa,
H., Eds.; Springer-Verlag: NewYork, 1982.
(12) The enantioselectivity was increased to >98% after recrystallization
of the furan diol bisbenzoate.
(13) For specific conditions, see ref 11 and (a) Fujii, A.; Hashiguchi, S.;
Uematsu, N.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 118, 2521.
For catalyst preparation, see: (b) Haack, K.-J.; Hashiguchi, S.; Fujii, A.;
Ikariya, T.; Noyori, R. Angew. Chem., Int. Ed. Engl. 1997, 36, 285.
(
9) (a) Harris, J. M.; Keranen, M. D.; O’Doherty, G. A. J. Org. Chem.
999, 64, 2982. (b) Harris, J. M.; Keranen, M. D.; Nguyen, H.; Young, V.
G.; O’Doherty, G. A. Carbohydr. Res. 2000, 328, 17.
1
(
(
10) Haukaas, M. H.; O’Doherty, G. A. Org. Lett. 2001, 3, 401.
11) Haukaas, M. H.; O’Doherty, G. A. Org. Lett. 2001, 3, 3899.
1772
Org. Lett., Vol. 4, No. 10, 2002